Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 5 |
NetGPI | no | yes: 0, no: 5 |
Related structures:
AlphaFold database: A4I2B1
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 137 | 141 | PF00656 | 0.536 |
CLV_NRD_NRD_1 | 150 | 152 | PF00675 | 0.485 |
CLV_NRD_NRD_1 | 51 | 53 | PF00675 | 0.502 |
CLV_PCSK_FUR_1 | 117 | 121 | PF00082 | 0.520 |
CLV_PCSK_KEX2_1 | 119 | 121 | PF00082 | 0.464 |
CLV_PCSK_KEX2_1 | 150 | 152 | PF00082 | 0.525 |
CLV_PCSK_PC1ET2_1 | 119 | 121 | PF00082 | 0.442 |
CLV_PCSK_SKI1_1 | 21 | 25 | PF00082 | 0.560 |
CLV_PCSK_SKI1_1 | 53 | 57 | PF00082 | 0.510 |
DOC_WW_Pin1_4 | 1 | 6 | PF00397 | 0.700 |
DOC_WW_Pin1_4 | 7 | 12 | PF00397 | 0.622 |
DOC_WW_Pin1_4 | 75 | 80 | PF00397 | 0.613 |
LIG_Clathr_ClatBox_1 | 133 | 137 | PF01394 | 0.421 |
LIG_Clathr_ClatBox_1 | 143 | 147 | PF01394 | 0.446 |
LIG_FHA_1 | 165 | 171 | PF00498 | 0.497 |
LIG_FHA_1 | 2 | 8 | PF00498 | 0.614 |
LIG_FHA_1 | 27 | 33 | PF00498 | 0.453 |
LIG_FHA_2 | 64 | 70 | PF00498 | 0.628 |
LIG_FHA_2 | 92 | 98 | PF00498 | 0.570 |
LIG_Integrin_RGD_1 | 164 | 166 | PF01839 | 0.462 |
LIG_LIR_Apic_2 | 34 | 40 | PF02991 | 0.435 |
LIG_PCNA_PIPBox_1 | 126 | 135 | PF02747 | 0.456 |
LIG_PCNA_yPIPBox_3 | 119 | 133 | PF02747 | 0.463 |
LIG_PCNA_yPIPBox_3 | 21 | 32 | PF02747 | 0.463 |
LIG_SH2_CRK | 37 | 41 | PF00017 | 0.513 |
LIG_SH2_NCK_1 | 37 | 41 | PF00017 | 0.451 |
LIG_SH2_SRC | 132 | 135 | PF00017 | 0.472 |
LIG_SH2_STAP1 | 198 | 202 | PF00017 | 0.433 |
LIG_SH2_STAT5 | 132 | 135 | PF00017 | 0.403 |
LIG_SH3_3 | 5 | 11 | PF00018 | 0.617 |
LIG_SH3_3 | 62 | 68 | PF00018 | 0.539 |
LIG_SUMO_SIM_par_1 | 132 | 140 | PF11976 | 0.502 |
LIG_TRAF2_1 | 176 | 179 | PF00917 | 0.507 |
MOD_CK1_1 | 15 | 21 | PF00069 | 0.701 |
MOD_CK2_1 | 6 | 12 | PF00069 | 0.732 |
MOD_CK2_1 | 91 | 97 | PF00069 | 0.613 |
MOD_GlcNHglycan | 161 | 164 | PF01048 | 0.602 |
MOD_GSK3_1 | 132 | 139 | PF00069 | 0.437 |
MOD_GSK3_1 | 26 | 33 | PF00069 | 0.482 |
MOD_GSK3_1 | 63 | 70 | PF00069 | 0.631 |
MOD_GSK3_1 | 73 | 80 | PF00069 | 0.655 |
MOD_NEK2_1 | 153 | 158 | PF00069 | 0.562 |
MOD_NMyristoyl | 1 | 7 | PF02799 | 0.617 |
MOD_PIKK_1 | 182 | 188 | PF00454 | 0.466 |
MOD_PIKK_1 | 89 | 95 | PF00454 | 0.639 |
MOD_PKA_2 | 73 | 79 | PF00069 | 0.654 |
MOD_Plk_4 | 32 | 38 | PF00069 | 0.465 |
MOD_ProDKin_1 | 1 | 7 | PF00069 | 0.701 |
MOD_ProDKin_1 | 75 | 81 | PF00069 | 0.605 |
MOD_SUMO_rev_2 | 63 | 73 | PF00179 | 0.612 |
TRG_DiLeu_BaEn_1 | 190 | 195 | PF01217 | 0.488 |
TRG_ENDOCYTIC_2 | 121 | 124 | PF00928 | 0.600 |
TRG_ER_diArg_1 | 149 | 151 | PF00400 | 0.514 |
TRG_Pf-PMV_PEXEL_1 | 111 | 115 | PF00026 | 0.531 |
TRG_Pf-PMV_PEXEL_1 | 122 | 126 | PF00026 | 0.425 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I6B4 | Leptomonas seymouri | 40% | 93% |
A0A3S7X005 | Leishmania donovani | 99% | 100% |
A4HD51 | Leishmania braziliensis | 71% | 100% |
Q4Q914 | Leishmania major | 90% | 100% |